Cerebral Palsy Spastic DiplegiaNCT07731074
Oculomotor Training in Spastic Diplegia: Effects on Postural Stability and Motor Proficiency
A study testing Oculomotor Training and Conventional Physiotherapy in people with Cerebral Palsy Spastic Diplegia, run by Cairo University at 1 site in Egypt.
Trial summary
This randomized clinical trial investigates the effect of oculomotor training on postural stability and motor proficiency in children with spastic diplegia. Participants will undergo structured oculomotor exercises designed to enhance visual-motor integration and balance control. Read more about this study
- Who is it for?
- Ages 6 to 10 years
- Conditions the study is for
- Cerebral Palsy Spastic Diplegia
- What is being tested?
- Oculomotor Training and Conventional Physiotherapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 34 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jun 2026to 30 Nov 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 10 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Their ages will range from 6 to 10 years old. -The degree of spasticity will range from grade 1and1+ according to the Modified Ashworth Scale (MAS)-
- They will be at level I or II according to gross motor classification system (GMFCS).
- They will have mild and moderate visual impairment without (CVI) according to visual assessment scale.
- They will be able to follow verbal command or instructions.
Who cannot join
- Uncontrolled seizures.
- Severe vestibular dysfunction.
- Recent orthopedic surgery (within 6 months).
- Severe visual impairment
Trial locations and contacts
1 site in 1 country.
About this study
Official title: EFFECT OF OCULOMOTOR TRAINING ON POSTURAL STABILITY AND MOTOR PROFICIENCY IN CHILDREN WITH SPASTIC DIPLEGIA
This randomized clinical trial investigates the effect of oculomotor training on postural stability and motor proficiency in children with spastic diplegia. Participants will undergo structured oculomotor exercises designed to enhance visual-motor integration and balance control. Outcomes will be assessed using standardized measures of postural stability and motor proficiency before and after intervention. The study aims to determine whether targeted oculomotor training can improve functional motor performance and balance in this pediatric population.
By evaluating the effect of structured oculomotor training on postural stability and motor proficiency in children with spastic diplegia, the study seeks to establish whether visual-motor interventions can serve as effective adjuncts to conventional therapy. The rationale is grounded in neuroplasticity: repeated oculomotor exercises may strengthen neural pathways linking visual input to motor output, thereby improving balance and functional performance.
- Conditions
- Cerebral Palsy Spastic Diplegia
- Being tested
- Oculomotor Training, Conventional Physiotherapy
- Keywords
- Oculomotor training, Postural stability, Spastic diplegia ,Cerebral palsy, Motor proficiency, Pediatric rehabilitation
- Medical subject headings
- Cerebral Palsy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Oculomotor TrainingBehavioural
Exercises include saccadic eye movements, smooth pursuit, fixation, and visual scanning tasks.
Conventional PhysiotherapyBehavioural
physiotherapy focusing on stretching, strengthening, and balance training.
| Study group | Role | What they receive |
|---|---|---|
| Oculomotor Training + Conventional Physiotherapy | Experimental | Intervention: Participants receive a structured oculomotor training program in addition to Conventional Physiotherapy.
Details:
Exercises include saccadic eye movements, smooth pursuit, fixation, and visual scanning tasks.
Sessions: 45 minutes of Conventional Physiotherapy and 45 minutes of Oculomotor Training , 3 times per week, for 12 weeks.
Purpose: To evaluate whether oculomotor training enhances postural stability and motor proficiency beyond conventional therapy. Receives: Behavioral: Oculomotor Training; Behavioral: Conventional Physiotherapy |
| Conventional Physiotherapy Only | Active comparator | Participants receive standard physiotherapy focusing on stretching, strengthening, and balance training.
Details:
Sessions matched in duration and frequency to the experimental arm (45 minutes, 3 times per week, for 12 weeks).
Purpose: Serves as a comparator to determine the added value of oculomotor training. Receives: Behavioral: Conventional Physiotherapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postural Stability Index
Overall Stability Index (OSI) from the Biodex Balance System.
Measured: 12 weeks
Secondary outcomes (1)
Motor Proficiency
Measure: Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2).
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jul 2026
- Study start1 Jun 2026
- Primary completion15 Oct 2026 (estimated)
- Study completion30 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cerebral Palsy Spastic DiplegiaStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shimaa Aly Mohamed saied, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07731074
- Sponsor's protocol ID
- P.T.REC/012/006212
- Status last verified
- Jul 2026
- First submitted
- 23 Jul 2026
- Last updated
- 28 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: study report about our work and results will be published